Velaresol
Alternative Names: 12C79; BW 12C; BW 12C79Latest Information Update: 06 Dec 1999
Price :
$50 *
At a glance
- Originator GlaxoSmithKline
- Class Antianaemics; Antineoplastics; Radiosensitisers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Gastrointestinal cancer; Sickle cell anaemia
Most Recent Events
- 06 Dec 1999 Discontinued-Unspecified Phase in Sickle cell anaemia (unspecified route)
- 02 Dec 1999 Discontinued-I for Gastrointestinal cancer in United Kingdom (unspecified route)
- 02 Dec 1999 Discontinued-II for Cancer in United Kingdom (unspecified route)